Genmab | GEN - Ebit

股票价格
1,769.50
每天变化
33.50 1.93%
每月一次
1.03%
每年
29.68%
Q2 预测
1,613.20




Ebit 更改 日
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Almirall EUR 30.23M 12.8M 2025-12
Amarin USD -2.26M 564K 2025-12
Amgen USD 3.83B 130M 2026-03
argenx SE USD 371.14M 21.17M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Bayer EUR 1.11B 1.51B 2025-12
BioMarin Pharmaceutical USD 129.65M 68.74M 2026-03
Demant DKK 2.07B 201M 2025-12
Exelixis USD 251.34M 15.43M 2026-03
Fresenius Medical Care EUR 268M 395M 2026-03
Galapagos EUR 780.56M 822.23M 2025-12
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
GN Store Nord DKK 570M 230M 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Insmed USD -249.71M 11.64M 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD 4.18B 118M 2026-03
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
UCB EUR 1.29B 571M 2025-12